PharmaReports: Technology
LeadDiscovery offers full reports in selected areas of the pharmaceutical and biotech sector.
Each of the reports below has been especially selected by LeadDiscovery. Browse the reports or try our search engine.
The technology channel relates to all things biotech. Reports describing, for example, advances in peptide, protein, genomics/proteomics and cell based sciences are included. This channel also focuses on novel drug delivery technologies and novel screening tools
Showing results 151 - 200 of 277
- MYELODYSPLASTIC SYNDROME - Therapy Area Pipeline Report
- LEUKEMIA - Therapy Area Pipeline Report
- BREAST CANCER - Therapy Area Pipeline Report
- GASTRIC CANCER - Therapy Area Pipeline Report
- HEAD AND NECK CANCER - Therapy Area Pipeline Report
- Autoimmune Market Outlook to 2012
- Innovative and Targeted Cancer Therapies: Key technologies, new applications and leading players
- Decoding Big Pharmas R&D Strategy in Oncology
- Monoclonal Antibodies: strategic analysis of the mAb market out to 2012
- Pipeline Insight: Cancer Overview - Increasing diversity offers both high risk and reward
- The Future of Biosimilars: Key opportunities & emerging therapies
- Biomarker Technology Platforms for Cancer Diagnoses and Therapies
- Global Smoking Cessation Market Analysis & Forecasts - Preparing for the First Blockbuster
- Top Companies and Products in the RNA/DNA Therapy Products Market
- Drug Delivery Technology: Revolutionizing Diabetes Treatment
- Cell-Based Diagnostics: Technology, Applications, and Markets
- Analytical Chip Technology: U.S. Markets for Lab on a Chip, DNA/Gene, Protein, and other Microarrays
- Analysis of the Pharmaceutical Market to 2012 - Segmented by Drug Target Family
- Pipeline Insight: Molecular Targeted Cancer Therapies
- Stakeholder Insight: Renal Cancer - Targeted therapies rapidly take hold of market
- Biosimilars Series: Strategic issues - Potential remains uncertain
- Immunomodulators: Therapeutic Needs, Pipelines and Prospects
- Translational Medicine in Biopharmaceutical Research and Development
- The CNS Market Outlook
- The Gastrointestinal Market Outlook to 2012
- Licensing Strategies - Current Pharmaceutical Licensing Trends
- Hepatitis B (HBV) - Commercial and Pipeline Insight
- Pediatric Drugs - the Worldwide Market
- Autoimmune Disorders and Transplant Rejection - The Potential of T-cells Targeted Therapeutics
- Rheumatoid arthritis - Emerging drug discovery targets and therapeutic candidates
- Asthma Therapeutics - New treatment options and emerging drug discovery targets
- BAFF (BLys) and APRIL: Emerging Targets for autoimmune disease & Cancer Therapeutics
- Injectable Drug Delivery: Probing the Route to Growth
- Commercial and Pipeline Perspectives: Lower GI Disorders - Remicade Leads Growth as Novel Biologics
- Commercial and Pipeline Perspectives: Rheumatoid Arthritis - Novel Biologics Drive Innovation
- Commercial Insight: Vaccines - Reaching Adulthood
- Inflammatory Bowel Disease - Efficacy and Compliance Key to Maximizing Patient Share
- Stakeholder Opinions: HIV Vaccines - The Emperor Has No Clothes
- Stakeholder Opinions: Malignant Melanoma - High Hurdles, High Rewards, Are Vaccines Only Skin Deep?
- Emerging Drug Discovery Technologies: Building competitive advantage through lab-on-a-chip, nanotechnology and RNAi
- The Future of Monoclonal Antibody Therapeutics: Innovation in antibody engineering, key growth strategies and forecasts to 2011
- The Therapeutic Proteins Outlook To 2007: An analysis of leading products and late-stage pipeline developments
- Innovation in Drug Delivery: The future of nanotechnology and non-invasive protein delivery
- The Outlook For RNAi: Accelerating drug discovery and the development of RNAi therapeutics
- The Future Of Array Technologies: Impact on drug discovery and market growth in DNA, protein and tissue arrays
- The Future of Systems Biology: Emerging technologies and their impact on drug discovery, development and diagnostics
- The Emerging Drug Targets Outlook: An analysis of novel molecular targets to develop innovative new therapeutics
- Predictive ADME and Toxicology Strategies: Challenges and opportunities for in vivo, in vitro and in silico predictive technologies
- Opportunities in Stem Cell Research and Commercialization: Technology advances, regulatory impact and key players
- Commercial Opportunities from Biomarkers: Transforming drug discovery, clinical development and molecular diagnostics
Browse our theraputic areas for other entries:
- Oncology
- Cancer Immunotherapy
- Immunology & Inflammatory Diseases
- Infectious Diseases
- Psychiatric, Addictive & Sleep Disorders
- Pain
- Neurodegenerative & Neuroelectrophysiological Disorders
- Metabolic & Hormonal Disorders
- Cardiovascular Disorders
- GenitoUrinary Tract Disorders
- Technology
- Diagnostics & Devices
- Other Theraputic Areas, Pharmaceutical Strategy and Development